Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5743356 | 0.92 | IKBKB (0.56) | IKBKBCHUK | |
| SCHEMBL5744024 | 0.89 | IKBKB (0.59) | IKBKBCHUK | |
| Hydrochloric Acid SCHEMBL5741264 | 0.88 | IKBKB (0.68) | IKBKBCHUK | |
| Hydrochloric Acid SCHEMBL5743268 | 0.83 | IKBKB (0.63) | IKBKBCHUK | |
| Hydrochloric Acid SCHEMBL5743766 | 0.83 | IKBKB (0.69) | IKBKBCHUK | |
| Hydrochloric Acid SCHEMBL5742086 | 0.79 | IKBKB (0.76) | IKBKBCHUK | |
| SCHEMBL5743013 | 0.77 | ALOX5AP (0.40) | IKBKB | |
| Hydrochloric Acid SCHEMBL5742879 | 0.74 | IKBKB (0.63) | IKBKBCHUK | |
| Hydrochloric Acid SCHEMBL5743702 | 0.74 | IKBKB (0.98) | IKBKBCHUK | |
| SCHEMBL5741321 | 0.73 | IKBKB (0.59) | IKBKBCHUK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678146-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2006-07-12 | — | — | EP | claimed |
| WO-2005040133-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2005-05-06 | — | — | WO | claimed |
| EP-1678146-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | Pharmacia Corporation (US) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040133-A1 | PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2005-05-06 | — | — | WO | disclosed |